GOLDMAN Competition

38143CDP3

97.64 2.36 2.36%

Specify up to 10 symbols:

Low	Estimated	High
94.67	97.64	100.61

Details

Intrinsic

Valuation

Low	Real	High
84.29	87.25	107.40

Details

GOLDMAN Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between GOLDMAN and its competitors represents the degree of relationship between the price movements of corresponding bonds. A correlation of about +1.0 implies that the price of GOLDMAN and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of GOLDMAN SACHS GROUP does not affect the price movement of the other competitor.

	SHAK	PSFE	RAVE	KSPI	RICK	RUM	NOW	WFCF
SHAK		-0.24	0.81	-0.33	0.75	0.73	0.89	0.62	SHAK
PSFE	-0.24		-0.26	0.17	-0.37	-0.16	-0.42	-0.3	PSFE
RAVE	0.81	-0.26		-0.43	0.38	0.56	0.76	0.71	RAVE
KSPI	-0.33	0.17	-0.43		-0.07	0.01	-0.46	-0.22	KSPI
RICK	0.75	-0.37	0.38	-0.07		0.74	0.75	0.46	RICK
RUM	0.73	-0.16	0.56	0.01	0.74		0.67	0.66	RUM
NOW	0.89	-0.42	0.76	-0.46	0.75	0.67		0.66	NOW
WFCF	0.62	-0.3	0.71	-0.22	0.46	0.66	0.66		WFCF
	SHAK	PSFE	RAVE	KSPI	RICK	RUM	NOW	WFCF

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

High positive correlations

NOW	+ 0.89	SHAK
RAVE	+ 0.81	SHAK
NOW	+ 0.76	RAVE
RICK	+ 0.75	SHAK
NOW	+ 0.75	RICK
RUM	+ 0.74	RICK

High negative correlations

NOW	- 0.46	KSPI
KSPI	- 0.43	RAVE
NOW	- 0.42	PSFE
RICK	- 0.37	PSFE
KSPI	- 0.33	SHAK
WFCF	- 0.3	PSFE

Risk-Adjusted Indicators

There is a big difference between GOLDMAN Bond performing well and GOLDMAN Corporate Bond doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze GOLDMAN's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
SHAK	1.77	0.20	0.13	0.28	1.50	(2.27)	5.02	(2.89)	11.94
PSFE	2.12	(0.27)	0.00	(0.03)	0.00	0.00	5.20	(3.12)	31.72
RAVE	2.85	0.70	0.24	1.21	2.22	(3.66)	8.33	(4.90)	26.70
KSPI	2.24	(0.25)	0.00	(0.23)	0.00	0.00	4.85	(3.69)	21.57
RICK	1.65	(0.04)	0.04	0.09	1.48	(2.14)	3.64	(2.80)	10.05
RUM	3.53	0.16	0.07	0.20	3.76	(4.26)	8.96	(5.27)	27.96
NOW	1.40	0.22	0.16	0.31	1.26	(1.70)	3.04	(2.68)	8.12
WFCF	1.29	0.15	0.01	(1.43)	1.42	(1.57)	3.34	(2.07)	8.33

Unable to evaluate fundamental data of [SHAK, PSFE, RAVE, KSPI, RICK, RUM, NOW, WFCF] at this time. Please try again later

All Fundamental Data

GOLDMAN Competitive Analysis

The better you understand GOLDMAN competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, GOLDMAN's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across GOLDMAN's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	38143CDP3	SHAK	PSFE	RAVE	KSPI	RICK	RUM	NOW	WFCF
	2.36 97.64 GOLDMAN	1.04 133.73 Shake	0.51 19.88 Paysafe	2.73 3.01 Rave	2.15 106.40 Joint	0.81 52.46 RCI	0.42 7.10 Rumble	0.77 1,049 ServiceNow	1.00 12.11 Where
Market Volatility (90 Days Market Risk)	Very steady	Very steady	Not too volatile	Risky	Very steady	Very steady	Slightly risky	Very steady	Not too volatile
Market Performance (90 Days Performance)	Very Weak	Solid	Very Weak	Solid	Very Weak	OK	OK	Solid	Insignificant
Odds of Financial Distress (Probability Of Bankruptcy)	Below Average	Low	About Average	Very Low	Low	Below Average	Below Average	Very Low	Very Small
Current Valuation (Equity Enterprise Value)	Over Valued	Over Valued	Under Valued	Under Valued	Under Valued	Under Valued	Under Valued	Over Valued	Under Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Buy	Hold	Not Available	Strong Buy	Buy	Hold	Strong Buy	Strong Sell
Trade Advice (90 Days Macroaxis Advice)	Cautious Hold	Strong Buy	Strong Hold	Strong Buy	Strong Hold	Buy	Cautious Hold	Strong Buy	Cautious Hold
Current Ratio	N/A	2.89	1.06	3.48	N/A	1.69	26.89	1.24	2.24
Net Asset	N/A	1.61 B	5.23 B	15.82 M	6.82 T	610.88 M	295.71 M	17.39 B	16.29 M
Profit Margin	N/A	0.0072	-0.0138	0.22	0.41	0.0167	-1.63	0.13	0.0842
EBITDA	N/A	111.74 M	435.88 M	3.72 M	998.8 B	67.02 M	(131.47 M)	1.29 B	3.33 M
Operating Margin	N/A	0.035	0.082	0.2	0.76	-0.029	-1.73	0.15	0.0912
Current Valuation	N/A	5.79 B	3.43 B	35.52 M	17.67 B	712.41 M	1.89 B	211.81 B	63.15 M
Price To Book	N/A	11.62	1.37	3.24	7.72	1.72	12.18	23.13	6.69
Retained Earnings	N/A	16.78 M	(2.26 B)	4.91 M	1.05 T	201.05 M	(145.2 M)	2.07 B	9.74 M
Current Asset	N/A	78.93 M	N/A	4.87 M	N/A	29.39 M	N/A	1.09 B	5.85 M
Five Year Return	N/A	N/A	N/A	N/A	N/A	0.49	N/A	N/A	N/A
Beta	N/A	1.82	1.92	0.51	-0.099	1.57	0.73	0.99	0.52
Number Of Employees	N/A	12.2 K	3.2 K	21	N/A	3.78 K	158	22.67 K	89
Shares Outstanding	N/A	40.03 M	60.77 M	14.71 M	190.02 M	8.96 M	118.58 M	206.32 M	5.28 M
Cash Flow From Operations	N/A	132.14 M	234.02 M	2.74 M	1.11 T	59.13 M	(92.91 M)	3.4 B	2.82 M
Annual Yield	N/A	N/A	N/A	N/A	0.0672	0.0054	N/A	N/A	N/A
Total Debt	N/A	771.33 M	2.53 B	957 K	222.16 B	277.9 M	2.61 M	2.28 B	2.8 M
Return On Equity	N/A	0.019	-0.0268	0.22	0.83	0.0177	-0.52	0.16	0.21
Return On Asset	N/A	0.0102	0.0188	0.12	0.16	0.0407	-0.31	0.047	0.0984
Number Of Shares Shorted	N/A	3.84 M	1.36 M	70.53 K	789.96 K	731.65 K	15.23 M	3.24 M	13.88 K
Book Value Per Share	N/A	11.4	14.45	0.91	7052.62	29.7	0.9	45.03	1.97
Current Liabilities	N/A	24 M	N/A	5.5 M	N/A	24.46 M	N/A	731.64 M	1.32 M
Total Asset	N/A	1.61 B	5.23 B	15.82 M	6.82 T	610.88 M	295.71 M	17.39 B	16.29 M
Debt To Equity	N/A	1.65	2.96	0.14	N/A	0.98	0.004	0.47	0.24
Short Ratio	N/A	3.59	3.97	1.19	3.81	9.67	6.84	2.46	2.55
Target Price	N/A	131.14	21.33	2.5	68957.52	98.0	8.0	1007.9	18.3
Last Dividend Paid	N/A	N/A	N/A	N/A	3400.0	0.23	N/A	N/A	N/A
Shares Owned By Institutions	N/A	99.2	53.75	28.94	25.44	51.05	22.8	91.7	19.48
Market Capitalization	N/A	5.62 B	1.2 B	43.1 M	21.11 B	466.02 M	2.02 B	214.86 B	63.28 M
Price To Earning	N/A	112.61	N/A	3.39	N/A	21.54	N/A	415.52	64.18
Price To Earnings To Growth	N/A	2.55	N/A	N/A	N/A	0.79	N/A	2.82	N/A
Price To Sales	N/A	4.65	0.71	3.56	0.0089	1.57	25.75	20.53	2.46
Net Income	N/A	20.99 M	(20.25 M)	2.47 M	841.35 B	29.1 M	(116.42 M)	1.73 B	2.15 M
Earnings Per Share	N/A	0.2	-0.39	0.18	10.12	0.52	-0.65	6.46	0.36
Shares Owned By Insiders	N/A	5.07	24.08	24.75	24.8	8.21	25.68	0.18	49.3
Revenue	N/A	1.09 B	1.6 B	12.15 M	1.89 T	293.79 M	80.96 M	8.97 B	25.14 M
Working Capital	N/A	170.37 M	193.82 M	7.52 M	974.47 B	(10.51 M)	204.45 M	412 M	3.23 M
Cash And Equivalents	N/A	357.96 M	220.19 M	7.72 M	N/A	37.5 M	356.68 M	1.47 B	6.41 M
Cash Per Share	N/A	9.11	0.3	0.47	N/A	4.06	0.93	19.55	1.08
Gross Profit	N/A	313.04 M	882.11 M	7.93 M	N/A	227.86 M	(4.36 M)	5.67 B	10.47 M
Day Typical Price	97.64	133.54	20.09	3.01	107.62	52.33	7.17	1046.6	11.98
Accumulation Distribution	N/A	5246.3	15240.69	734.22	4144.25	315.99	64900.12	7554.7	119.89
Market Facilitation Index	N/A	0.0	0.0	0.0	0.0	0.0	N/A	0.0	2.0E-4
Daily Balance Of Power	(9,223,372,036,855)	0.7041	0.101	0.5333	(0.64)	0.6774	(0.09)	0.5899	0.2308
Period Momentum Indicator	(2.36)	1.38	0.1	0.08	(2.34)	0.42	(0.03)	8.04	0.12
Rate Of Daily Change	0.98	1.01	1.01	1.03	0.98	1.01	1.0	1.01	1.01
Day Median Price	97.64	133.44	20.2	3.01	108.23	52.27	7.21	1045.19	11.91
Price Action Indicator	(1.18)	0.98	(0.27)	0.045	(2.99)	0.4	(0.13)	8.28	0.26
Relative Strength Index	56.9	77.62	81.88	50.05	52.67	77.46	75.25	78.01	53.64
Coefficient Of Variation	1153.35	664.14	(7,641)	530.86	(2,038)	1203.32	1277.4	486.26	1124.44
Mean Deviation	1.75	1.77	2.12	2.85	2.24	1.65	3.53	1.4	1.29
Jensen Alpha	0.1077	0.1957	(0.27)	0.7048	(0.25)	(0.04)	0.1555	0.2186	0.1515
Total Risk Alpha	(0.16)	(0.01)	(0.65)	0.1484	(0.66)	(0.17)	(0.36)	0.0853	(0.11)
Sortino Ratio	0.0308	0.1269	N/A	0.2357	N/A	0.0407	0.0659	0.1567	0.0145
Downside Variance	5.85	2.91	N/A	7.93	N/A	2.71	15.45	2.16	2.92
Standard Deviation	2.31	2.27	3.92	4.19	3.25	2.31	4.91	1.73	1.69
Kurtosis	0.3178	0.885	26.46	7.25	8.13	2.43	2.59	0.2018	0.3496
Potential Upside	3.36	5.02	5.2	8.33	4.85	3.64	8.96	3.04	3.34
Treynor Ratio	0.2666	0.2813	(0.03)	1.21	(0.23)	0.0946	0.1973	0.3136	(1.43)
Maximum Drawdown	10.94	11.94	31.72	26.7	21.57	10.05	27.96	8.12	8.33
Variance	5.32	5.15	15.38	17.55	10.57	5.36	24.12	2.99	2.85
Market Risk Adjusted Performance	0.2766	0.2913	(0.02)	1.22	(0.22)	0.1046	0.2073	0.3236	(1.42)
Risk Adjusted Performance	0.0731	0.122	(0)	0.1525	(0.03)	0.0704	0.0684	0.1632	0.0736
Skewness	(0.11)	0.7319	(4.03)	1.98	(1.41)	1.24	1.03	0.1543	0.1556
Semi Deviation	2.14	1.5	N/A	2.22	N/A	1.48	3.76	1.26	1.42
Information Ratio	0.0323	0.0953	(0.05)	0.1584	(0.09)	0.0289	0.0528	0.1332	0.0147
Value At Risk	(4.30)	(2.89)	(3.12)	(4.90)	(3.69)	(2.80)	(5.27)	(2.68)	(2.07)
Expected Short fall	(1.84)	(2.27)	N/A	(3.66)	N/A	(2.14)	(4.26)	(1.70)	(1.57)
Downside Deviation	2.42	1.7	N/A	2.82	N/A	1.65	3.93	1.47	1.71
Semi Variance	4.58	2.25	N/A	4.92	N/A	2.19	14.17	1.6	2.01

GOLDMAN Competition Performance Charts

Five steps to successful analysis of GOLDMAN Competition

GOLDMAN's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by GOLDMAN SACHS GROUP in relation to its competition. GOLDMAN's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of GOLDMAN in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact GOLDMAN's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to GOLDMAN SACHS GROUP, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your GOLDMAN position

In addition to having GOLDMAN in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Pharmaceutical Products Thematic Idea Now

Pharmaceutical Products

Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Pharmaceutical Products theme has 61 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Pharmaceutical Products Theme or any other thematic opportunities.

View All Next

Launch

Other Information on Investing in GOLDMAN Bond

GOLDMAN financial ratios help investors to determine whether GOLDMAN Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GOLDMAN with respect to the benefits of owning GOLDMAN security.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC